Literature DB >> 1386679

Carbogen and nicotinamide: expectations too high?

J M Brown1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1386679     DOI： 10.1016/0167-8140(92)90281-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  3 in total

1.  Letter in response to paper by Abratt et al., Cancer Chemother Pharmacol (1992) 30: 495.

Authors:  S Senan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

3.  Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.

Authors:  V M Laurence; R Ward; I F Dennis; N M Bleehen
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.